Acute Care Volume 24, Issue 6

Medication Safety Alert! March 28, 2019

In this week's issue:

Featured article

The latest issue of ISMP’s QuarterWatch™ (see description in box below) focuses on two older but widely used analogs of the inhibitory gamma-aminobutyric acid (GABA) neurotransmitter and a new type of antipsychotic medication approved for Parkinson’s disease psychosis. Key findings include:

  • Extensive patterns of potentially unsafe use of the GABA analogs, gabapentin (NEURONTIN, others) and pregabalin (LYRICA)

  • New questions about both the safety and benefits of pimavanserin (NUPLAZID)

The following is a summary of the full QuarterWatch™ report, which can be found, with additional...

Access this Newsletter

Purchasing Options

Purchase access to this individual issue

Purchase a year's access to this bi-weekly publication (25 issues)